SCHEMBL25466697

SCHEMBL25466697

CC(C)c1ncc2ncc(=O)n(C)c2n1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 20/20 0.58
ALDH1A1 P00352 13/20 0.58
CASP1 P29466 11/20 0.58
CASP7 P55210 11/20 0.58
HSD17B10 Q99714 11/20 0.58
HPGD P15428 5/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C19 P33261 6/20 0.55
USP2 O75604 5/20 0.55
GLA P06280 2/20 0.55
CYP3A4 P08684 6/20 0.51
TSHR P16473 4/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
CYP2C9 P11712 4/20 0.51
MAPK1 P28482 3/20 0.51
CLK4 Q9HAZ1 7/20 0.49
ALOX15 P16050 1/20 0.38
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17807800 0.82 CYP1A2 (0.39) CYP1A2ALDH1A1CASP1CASP7HSD17B10
SCHEMBL17813499 0.77 CYP1A2 (0.63) CYP1A2ALDH1A1CASP1CASP7HSD17B10
SCHEMBL31532069 0.76 CYP1A2 (0.61) CYP1A2ALDH1A1CASP1CASP7HSD17B10
SCHEMBL31532070 0.76 CYP1A2 (0.61) CYP1A2ALDH1A1CASP1CASP7HSD17B10
SCHEMBL31532063 0.75 CYP1A2 (0.69) CYP1A2ALDH1A1CASP1CASP7HSD17B10
SCHEMBL17813457 0.74 GRM5 (0.38) CYP1A2CYP2D6CYP3A4
SCHEMBL31532102 0.73 CYP1A2 (0.58) CYP1A2ALDH1A1CASP1CASP7HSD17B10
SCHEMBL25462034 0.72 ADORA2A (0.32) KMT2A
SCHEMBL17807736 0.69 CDK2 (0.40)
SCHEMBL18898667 0.69 SLC9A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023083297-A1 SMALL MOLECULE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 1 (USP1) AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2023-05-19 WO disclosed